Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Cancer Medicine|January 28, 2023
Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patientsJulia Walter, Diego Kauffmann-Guerrero, Thomas Muley, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Translational Lung Cancer Research|September 21, 2020
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectivesSabine Wessels, Thomas Muley, Petros Christopoulos, et al.
Discover Oncology|October 3, 2023
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC scoreKarla Rubio, Jason M Müller, Aditi Mehta, et al.
Human Genetics|February 2, 2013
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controlsDarren R Brenner, Paul Brennan, Paolo Boffetta, et al.
Ebiomedicine|November 8, 2020
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNASteffen Dietz, Petros Christopoulos, Zhao Yuan, et al.
Human Genetics|June 7, 2016
Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controlsDarren R Brenner, Paul Brennan, Paolo Boffetta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort AnalysisSarina Bains, Takashi Eguchi, Arne Warth, et al.
Oncotarget|January 6, 2015
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancersEvgeny A Moskalev, Pouria Jandaghi, Mahdi Fallah, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Cancer Medicine|January 28, 2023
Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patientsJulia Walter, Diego Kauffmann-Guerrero, Thomas Muley, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Translational Lung Cancer Research|September 21, 2020
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectivesSabine Wessels, Thomas Muley, Petros Christopoulos, et al.
Discover Oncology|October 3, 2023
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC scoreKarla Rubio, Jason M Müller, Aditi Mehta, et al.
Human Genetics|February 2, 2013
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controlsDarren R Brenner, Paul Brennan, Paolo Boffetta, et al.
Ebiomedicine|November 8, 2020
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNASteffen Dietz, Petros Christopoulos, Zhao Yuan, et al.
Human Genetics|June 7, 2016
Erratum to: Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controlsDarren R Brenner, Paul Brennan, Paolo Boffetta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort AnalysisSarina Bains, Takashi Eguchi, Arne Warth, et al.
Oncotarget|January 6, 2015
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancersEvgeny A Moskalev, Pouria Jandaghi, Mahdi Fallah, et al.
Pageof 23